151 related articles for article (PubMed ID: 19961245)
21. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
22. Interphase cytogenetics of gastric carcinoma: fluorescence in situ hybridization (FISH) applied to cells obtained from formalin-fixed paraffin-embedded tissues.
Gomyo Y; Andachi H; Nagao K; Ikeguchi M; Ito H
Pathol Int; 1995 Mar; 45(3):227-32. PubMed ID: 7787993
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetics of papillary renal cell tumors.
Kovacs G; Fuzesi L; Emanual A; Kung HF
Genes Chromosomes Cancer; 1991 Jul; 3(4):249-55. PubMed ID: 1958590
[TBL] [Abstract][Full Text] [Related]
24. Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors.
Hagenkord JM; Parwani AV; Lyons-Weiler MA; Alvarez K; Amato R; Gatalica Z; Gonzalez-Berjon JM; Peterson L; Dhir R; Monzon FA
Diagn Pathol; 2008 Nov; 3():44. PubMed ID: 18990225
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
26. A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays.
Li MM; Monzon FA; Biegel JA; Jobanputra V; Laffin JJ; Levy B; Leon A; Miron P; Rossi MR; Toruner G; Alvarez K; Doho G; Dougherty MJ; Hu X; Kash S; Streck D; Znoyko I; Hagenkord JM; Wolff DJ
Cancer Genet; 2015 Nov; 208(11):525-36. PubMed ID: 26454669
[TBL] [Abstract][Full Text] [Related]
27. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
[TBL] [Abstract][Full Text] [Related]
28. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility and performance of virtual karyotyping with SNP microarrays for the detection of chromosomal imbalances in formalin-fixed paraffin-embedded tissues.
Alvarez K; Kash SF; Lyons-Weiler MA; Kim HJ; Peterson LE; Mathai B; Hagenkord JM; Monzon FA
Diagn Mol Pathol; 2010 Sep; 19(3):127-34. PubMed ID: 20736741
[TBL] [Abstract][Full Text] [Related]
31. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
[TBL] [Abstract][Full Text] [Related]
32. Fluorescent cytogenetics of renal cell neoplasms.
Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Ficarra V; Novara G; Menestrina F; Chilosi M; Martignoni G
Pathologica; 2008 Dec; 100(6):454-60. PubMed ID: 19475886
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetics profiles of renal carcinoma].
Dugay F; Dagher J; Verhoest G; Henry C; Jaillard S; Arlot-Bonnemains Y; Bensalah K; Vigneau C; Rioux-Leclercq N; Belaud-Rotureau MA
Morphologie; 2014 Mar; 98(320):1-7. PubMed ID: 24656859
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
[TBL] [Abstract][Full Text] [Related]
37. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality.
Hahm C; Mun YC; Seong CM; Chung WS; Huh J
Ann Lab Med; 2012 Nov; 32(6):445-9. PubMed ID: 23130347
[TBL] [Abstract][Full Text] [Related]
38. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
39. Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma.
Brunelli M; Delahunt B; Ficarra V; Gobbo S; Eccher A; Cossu-Rocca P; Zattoni F; Cheng L; Eble JN; Martignoni G
Anal Quant Cytol Histol; 2009 Dec; 31(6):401-9. PubMed ID: 20698356
[TBL] [Abstract][Full Text] [Related]
40. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
Kovacs G
Am J Pathol; 1989 Jan; 134(1):27-34. PubMed ID: 2913826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
